Citations

Showing 10 of 107890 citations.

Cross-Reactivity of BNP, NT-proBNP, and proBNP in Commercial BNP and NT-proBNP Assays: Preliminary Observations from the IFCC Committee for Standardization of Markers of Cardiac Damage
Luckenbill, Kristin, Christenson, Robert H. , Jaffe, Allan S. , Mair, Johannes , Ordóñez‐Llanos, Jordi , Pagani, Franca, Tate, Jillian R., Wu, Alan H.B. , Ler, Ranka, Apple, Fred S. , Jaffe, Allan S.

Mayo Clinic

Clinical Chemistry | February 29, 2008 | Volume: 54 | Issue: 3 | Pages: 619-621

10.1373/clinchem.2007.097998 | PMID 18310156 Get It

Are You Including Genomics in Nursing Practice?
Pestka, Elizabeth L.

Mayo Clinic

Journal of the American Psychiatric Nurses Association | February 29, 2008 | Volume: 14 | Issue: 1 | Pages: 63-68

10.1177/1078390307311974 | PMID 21672882 Get It

A national consensus panel representing 48 nursing organizations, including the American Psychiatric Nurses Association, identified and endorsed essential genetic and genomic competencies for all registered nurses regardless of academic preparation, role, or clinical specialty. The competencies were designed to guide academic curricula, continuing education, and specialty certification. A 5-year implementation plan for these competencies includes components applicable to practicing psychiatric nurses, regulatory and quality control issues, and academics. This article will describe the implementation strategies identified, some examples of genetics and genomics nursing activities in the psychiatric specialty, and recommendations that support the national implementation plan. J Am Psychiatr Nurses Assoc, 2008; 14(1), 63-68. DOI: 10.1177/1078390307311974
Photo-Cross-Linked Hybrid Polymer Networks Consisting of Poly(propylene fumarate) and Poly(caprolactone fumarate): Controlled Physical Properties and Regulated Bone and Nerve Cell Responses
Wang, Shanfeng , Kempen, Diederik H.R. , Simha, N.K., Lewis, Jack L. , Windebank, Anthony J. , Yaszemski, Michael J. , Lu, Lichun

Mayo Clinic

Biomacromolecules | February 29, 2008 | Volume: 9 | Issue: 4 | Pages: 1229-1241

10.1021/bm7012313 | PMID 18307311 Get It

Development of a Metropolitan Matrix of Primary Stroke Centers
Bobrow, Bentley J., Paulsen, Mary, Demaerschalk, Bart M.

Mayo Clinic

Stroke | February 29, 2008 | Volume: 39 | Issue: 4 | Pages: 1246-1253

10.1161/strokeaha.107.500678 | PMID 18309157 Get It

Background and Purpose— In 1998, 2947 patients in metropolitan Phoenix were hospitalized for acute cerebral infarction. Only 2 of the 26 regional hospitals satisfied criteria for primary stroke center (PSC) designation. Fewer than 1% of patients with ischemic stroke received tissue plasminogen activator for thrombolysis. We sought to develop and evaluate the effectiveness of a metropolitan prehospital emergency medical system for effectively identifying and transporting patients with acute stroke to a matrix of predesignated PSCs and increasing to 20% the proportion of all such patients receiving tissue plasminogen activator. Methods— The American Stroke Association Phoenix Operation Stroke partnered with the Arizona Emergency Medical Systems in 1998 to 1999 to list goals and objectives, identify key stakeholders, and develop committees to address community education, emergency medical system training, and PSC designation. Results— Over 8 years, emergency medical system personnel were trained to identify and transport patients with acute stroke to PSCs, 8 hospitals met PSC criteria, the metropolitan matrix of PSCs became operational (in 2003), and 18% of patients with acute ischemic stroke received thrombolysis. Conclusions— It is feasible to develop and operationalize a successful metropolitan-wide matrix of PSCs to accommodate emergency medical system-identified and transported patients with acute stroke in a 9000-square-mile region with a population of 3.5 million people.
In Reply
Höchster, Howard S. , Grothey, Axel

Mayo Clinic

Journal of Clinical Oncology | February 28, 2008 | Volume: 26 | Issue: 7 | Pages: 1189-1189

10.1200/jco.2007.15.4369 Get It

An Anomalous Haplotype Distribution of the Arrestin Domain–Containing 4 Gene ( ARRDC4 ) Haplotypes in Caucasians
Knoll, Bettina M. , Goldammer, Mark, Wojewoda, Agnieszka, Flügge, Jana, Johne, Andreas , Mrozikiewicz, P.M., Roots, Ivar, Köpke, Karla

Mayo Clinic

Genetic Testing | February 28, 2008 | Volume: 12 | Issue: 1 | Pages: 147-152

10.1089/gte.2007.0049 | PMID 18307387 Get It

Infection‐induced proteolysis of PGRP‐LC controls the IMD activation and melanization cascades in Drosophila
Schmidt, Rebecca L., Trejo, Theodore R., Plummer, Timothy B., Platt, Jeffrey L. , Tang, Amy , Tang, Amy H

Mayo Clinic

The FASEB Journal | February 28, 2008 | Volume: 22 | Issue: 3 | Pages: 918-929

10.1096/fj.06-7907com | PMID 18308747 Get It

The Drosophila immune deficiency (IMD) pathway, homologous to the mammalian tumor necrosis factor (TNF‐α) signaling pathway, initiates antimicrobial peptide (AMP) production in response to infection by gram‐negative bacteria. A membrane‐spanning peptidoglycan recognition protein, PGRP‐LC, functions as the receptor for the IMD pathway. This receptor is activated via pattern recognition and binding of monomeric peptidoglycan (DAP‐type PGN) through the PGRP ectodomain. In this article, we show that the receptor PGRP‐LC is down‐regulated in response to Salmonella/Escherichia coli infection but is not affected by Staphylococcus infection in vivo, and an ectodomain‐deleted PGRP‐LC lacking the PGRP domain is an active receptor. We show that the receptor PGRP‐LC regulates and integrates two host defense systems: the AMP production and melanization. A working model is proposed in which pathogen invasion and tissue damage may be monitored through the receptor integrity of PGRP‐LC after host and pathogen are engaged via pattern recognition. The irreversible cleavage or down‐regulation of PGRP‐LC may provide an additional cue for the host to distinguish pathogenic microbes from nonpathogenic ones and to subsequently activate multiple host defense systems in Dro‐sophila, thereby effectively combating bacterial infection and initiating tissue repair.—Schmidt, R. L., Trejo, T. R., Plummer, T. B., Platt, J. L., Tang, A. H. Infection‐induced proteolysis of PGRP‐LC controls the IMD activation and melanization cascades in Drosophila. FASEB J . 22, 918–929 (2008)
Associations Between Diabetes and Clinical Markers of Benign Prostatic Hyperplasia Among Community-Dwelling Black and White Men
Sarma, Aruna V. , Burke, J. P., Jacobson, Debra J., McGree, Michaela E. , Sauver, Jennifer L. St. , Lieber, Michael M., Herman, William, Montie, James E. , Jacobsen, Steven J. , Girman, Cynthia J. , Macoska, Jill A. , St Sauver, Jennifer L

Mayo Clinic

Diabetes Care | February 28, 2008 | Volume: 31 | Issue: 3 | Pages: 476-482

10.2337/dc07-1148 | PMID 18071006 Get It

OBJECTIVE—The aim of this study was to examine associations between diabetes and clinical markers of benign prostatic hyperplasia (BPH) in community-dwelling white and black men aged 40–79 years. RESEARCH DESIGN AND METHODS—Data from the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study were combined for a total study sample of 2,484 men. Severity of lower urinary tract symptoms (LUTS), peak urinary flow rates, prostate volume, and serum prostate-specific antigen (PSA) levels were examined by self-reported physician-diagnosed diabetes. RESULTS—Overall, 170 men (6.8%) reported a history of diabetes. Increased irritative LUTS and specifically nocturia were positively associated with diabetes. These patterns were consistent across race and persisted after adjustment for age, BMI, and various indicators of socioeconomic status. Furthermore, the relationship between irritative LUTS and diabetes was greater in black men. No significant associations were observed between diabetes and prostate volume, PSA level, and peak urinary flow rate. CONCLUSIONS—Our multiethnic community-based study demonstrates positive associations between diabetes and irritative LUTS and nocturia. Moreover, the association between irritative LUTS and diabetes is increased in black men. There was no strong evidence for an association between diabetes and BPH across measures more specific to BPH (i.e., prostate volume, PSA, and peak urinary flow rate). Taken together, our findings suggest that the presence of diabetes may be less related to prostate growth and more related to the dynamic components of lower urinary tract function. Further evaluations of the association between diabetes and BPH and related racial variations are warranted.
Predictors of Medication Errors Among Elderly Hospitalized Patients
Picone, Debra M., Titler, Marita G., Dochterman, Joanne McCloskey, Shever, Leah L. , Kim, Taikyoung, Abramowitz, Paul W., Kanak, Mary, Qin, Rui

Mayo Clinic

American Journal of Medical Quality | February 27, 2008 | Volume: 23 | Issue: 2 | Pages: 115-127

10.1177/1062860607313143 | PMID 18305099 Get It

Utility of the Advanced Chronic Kidney Disease Patient Management Tools: Case Studies
Patwardhan, Meenal, Matchar, David B. , Samsa, Gregory P., Haley, William E.

Mayo Clinic

American Journal of Medical Quality | February 27, 2008 | Volume: 23 | Issue: 2 | Pages: 105-114

10.1177/1062860607313142 | PMID 18305098 Get It